“Meta-guidelines” for the management of patients with schizophrenia

Stephen M. Stahl, Debbi A. Morrissette, Leslie Citrome, Stephen R. Saklad, Michael A. Cummings, Jonathan M. Meyer, Jennifer A. O'day, Laura J. Dardashti, Katherine D. Warburton

    Research output: Contribution to journalArticle

    36 Scopus citations

    Abstract

    Guidelines for treating various conditions can be helpful in setting practice standards, but the presence of several sets of guidelines from different countries, experts, and settings, written at different times, can also create confusion. Here we provide a “guideline of guidelines” for the treatment of schizophrenia, or “meta-guidelines,” which not only reconcile the various existing standards but also update them to include the use of several newer agents, most of which were marketed following the publication of existing standards.

    Original languageEnglish (US)
    Pages (from-to)150-162
    Number of pages13
    JournalCNS spectrums
    Volume18
    Issue number3
    DOIs
    StatePublished - Apr 16 2013

      Fingerprint

    Keywords

    • Assessment
    • acute
    • antipsychotics
    • depot
    • maintenance

    ASJC Scopus subject areas

    • Clinical Neurology
    • Psychiatry and Mental health

    Cite this

    Stahl, S. M., Morrissette, D. A., Citrome, L., Saklad, S. R., Cummings, M. A., Meyer, J. M., O'day, J. A., Dardashti, L. J., & Warburton, K. D. (2013). “Meta-guidelines” for the management of patients with schizophrenia. CNS spectrums, 18(3), 150-162. https://doi.org/10.1017/S109285291300014X